Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets
Authors:
- Geesje M. Dallinga-ThieGDGeesje M. Dallinga-Thie
- Robin P.F. DullaartRDRobin P.F. Dullaart
- 1 January 2010
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1801 (1) , 89-94